Explanation for the choice of comparators {6b}
The control group will be selected by the same inclusion and exclusion criteria as the intervention group and undergo the usual standard of care treatment with terlipressin and albumin. Thus, the outcome in this group will reflect the status quo in therapy of patients suffering from HRS-AKI. The patients in the treatment group are also treated with standard of care and then with a TIPS. Consequently, any difference in the outcome between both groups should be attributable to the TIPS. Due to the nature of the intervention, a double-blind design is not possible.